Allogene Therapeutics
Allogene Therapeutics, based in South San Francisco, develops allogeneic chimeric antigen receptor T cell products for cancer and autoimmune disease.
SCHEDULE 13GNov 16Latest SEC filing
Nov 3Latest story
Allogene Therapeutics, based in South San Francisco, develops allogeneic chimeric antigen receptor T cell products for cancer and autoimmune disease.